GlycoNet team at the University of Alberta builds on previous work to find a new direction for potential treatment of neurodegenerative diseases like Huntington’s.
Tag: Parkinson's Disease
Harnessing the power of carbohydrates to improve our health
A better understanding of complex molecules called glycans will bring us closer to disease treatments and innovative solutions to health challenges, say leading researchers.
GlycoNet partner company, Alectos Therapeutics, enters ground-breaking $700 million agreement with Biogen
This collaboration combines Alectos’ expertise in small-molecule therapeutics with Biogen’s development capabilities in movement disorders.